Saint Martin d'Hères, France

Sophie Ple

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sophie Ple

Introduction

Sophie Ple is a notable inventor based in Saint Martin d'Hères, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit pathogenic infections. Her work is characterized by a commitment to advancing medical research and improving treatment options.

Latest Patents

Sophie Ple holds a patent for "Pseudomonas aeruginosa inhibitor compounds." This invention relates to a method of identifying molecules that inhibit the virulence machinery of Pseudomonas aeruginosa. The patent also encompasses novel compounds that can be used for preventing and/or treating infections caused by this pathogen, as well as pharmaceutical compositions designed for the same purpose. She has 1 patent to her name.

Career Highlights

Throughout her career, Sophie has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. These experiences have allowed her to contribute to groundbreaking research and development in her field.

Collaborations

Sophie Ple has collaborated with esteemed colleagues such as Yung-Sing Wong and Ina Attree. These partnerships have further enriched her research and innovation efforts.

Conclusion

Sophie Ple's work exemplifies the impact of innovative thinking in the realm of medical science. Her contributions to the development of compounds for treating infections highlight her dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…